Drug Shortage Report for SANDOZ OLOPATADINE

Last updated on 2019-09-10 History
Report ID 89412
Drug Identification Number 02358913
Brand name SANDOZ OLOPATADINE
Common or Proper name OLOPATADINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OLOPATADINE
Strength(s) 0.1%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5ml
ATC code S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2019-06-24
Estimated end date 2019-08-26
Actual end date 2019-09-06
Shortage status Resolved
Updated date 2019-09-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-09-10 French Compare
v7 2019-09-10 English Compare
v6 2019-08-14 French Compare
v5 2019-08-14 English Compare
v4 2019-07-24 French Compare
v3 2019-07-24 English Compare
v2 2019-07-16 French Compare
v1 2019-07-16 English Compare

Showing 1 to 8 of 8